论文信息 - Extensive Fibromuscular Dysplasia in a Patient with Parkinson Disease

Extensive Fibromuscular Dysplasia in a Patient with Parkinson Disease

ABSTRACT:The cause of fibromuscular dysplasia is not known. Ergot derivatives have been reported as a potential causative agent. The anti-Parkinson medication pergolide is an ergot derivative, but an association between fibromuscular dysplasia and this drug has not been previously reported.

M. Mauro | J. Jennette | S. Moll | Thomas H. Wang

[1] P. Pfitzenmeyer,et al. Pleuropulmonary changes induced by ergoline drugs. , 1996, The European respiratory journal.

[2] J. Parisi,et al. Arterial Fibromuscular Dysplasia Associated With Severe α1-Antitrypsin Deficiency , 1994 .

[3] P. Whelton,et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. , 1989, Hypertension.

[4] T. Lüscher,et al. Arterial fibromuscular dysplasia. , 1987, Mayo Clinic proceedings.

[5] A. Rushton. The genetics of fibromuscular dysplasia. , 1980, Archives of internal medicine.

[6] G. Paulson. Fibromuscular dysplasia, antiovulent drugs, and ergot preparations. , 1978, Stroke.

[7] M. Fiévez,et al. Ergotism Anatomo-clinical study of a case , 1975 .

[8] W. Fry,et al. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. , 1975, Archives of surgery.

[9] T. D. Johnson. Severe peripheral arterial constriction, acute ischemia of lower extremity with use of methysergide and ergotamine. , 1966, Archives of internal medicine.

[10] J. R. Young,et al. Severe arteriospasm after use of ergotamine tartrate suppositories. Report of a case. , 1961, JAMA.

[11] E. Wylie,et al. Roentgen diagnosis of fibromuscular hyperplasia of the renal arteries. , 1961, Radiology.

[12] Robert I. White,et al. Etiologic Factors in Renovascular Fibromuscular Dysplasia , 2005 .

[13] J. Olin,et al. Fibromuscular dysplasia. , 2012, Circulation.